ALLMedicine™ Acetylcholine Receptor Antibody Center
Research & Reviews 86 results
https://doi.org/10.1002/mus.27381
Muscle & Nerve; Lee I, Sanders D
Jul 22nd, 2021 - Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.|2021|Lee I,Sanders D,|
https://doi.org/10.1002/mus.27326
Muscle & Nerve; Usman U, Chrisman C et. al.
May 20th, 2021 - Eculizumab has been shown to be efficacious in acetylcholine receptor antibody-positive (AChR+ ) Myasthenia Gravis Foundation of America (MGFA) class II, III, and IV generalized myasthenia gravis (gMG) patients. However, it has not been studied in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084046
Medicine Liu C, Liu P et. al.
Apr 29th, 2021 - To evaluate the efficacy of double-filtration plasmapheresis (DFPP) treatment of myasthenia gravis (MG) through a systematic review and meta-analysis. PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Chinese Scient...
https://doi.org/10.1136/jnnp-2020-325511
Journal of Neurology, Neurosurgery, and Psychiatry; Kojima Y, Uzawa A et. al.
Mar 27th, 2021 - To investigate the association between changes in anti-acetylcholine receptor antibody (AChR Ab) levels induced by immunosuppressive treatment and myasthenia gravis (MG) prognosis at 1-year post-treatment in patients with MG. We included 53 consec...
https://doi.org/10.1111/ced.14645
Clinical and Experimental Dermatology; Toosi R, Teymourzadeh A et. al.
Mar 14th, 2021 - A role for nondesmoglein antigens in the pathogenesis of pemphigus vulgaris (PV) has been suggested in several studies. Acetylcholine receptors (AchR), are one of the most important groups of these antigens. However, the exact role of both antimus...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT03350659
Apr 5th, 2019 - Visit 1. Enroll, baseline evaluation of the patients Questionnaire Evaluate orthostatic hypotension symptom: Orthostatic Hypotension Questionnaire (OHQ) Quality of life: Korean version of Short-form 36 Depressive symptom: Korean version of Beck De...
News 4 results
https://www.medscape.com/viewarticle/953330
Jun 17th, 2021 - Efgartigimod (argenx) is an effective and well-tolerated therapy for patients with generalized myasthenia gravis (gMG), new research suggests. Results from the phase 3, randomized, placebo-controlled ADAPT trial showed that reduction in disease bu...
https://www.mdedge.com/clinicalneurologynews/article/210310/neuromuscular-disorders/placebo-response-negative-rituximab/page/0/1?channel=39313
Oct 17th, 2019 - Suggestions from the data The post hoc subgroup analysis should be interpreted with caution, and the study does not provide firm conclusions, Dr. Nowak noted.
https://www.medscape.com/viewarticle/764741
Jun 5th, 2012 - Autoimmune Autonomic Ganglionopathy With Reversible Cognitive Impairment Gibbons CH, Centi J, Vernino S, Freeman R Arch Neurol. 2012;69:461-466 Study Summary Autoimmune autonomic ganglionopathy (AAG) is a rare form of severe autonomic failure link...
https://www.mdedge.com/ccjm/article/92699/myasthenia-gravis-therapy-immunoadsorbent-may-eliminate-need-plasma-products
Abstract This in vitro study assessed the effectiveness of a new immunoadsorbent (Asahi IM-TR 350) in removing anti-acetylcholine receptor antibody from plasma with minimal loss of albumin. Plasma procured from a myasthenia gravis patient undergoi.
